35.SYSTEMIC ANTIFUNGAL USED IN VULVOVAGINAL CANDIDIASIS
A.FLUCOBAZOLE
B.NYSTATIN
C.GRISEOFULVIN
D.COTRIMAZOLE
ANS:FLUCONAZOLE
Vulvovaginal candidiasis (VVC) can be managed with either topical antifungal agents or a single dose of oral fluconazole. A single dose of oral fluconazole (150 mg) in acute episodes of VVC has been shown to yield clinical and microbiological efficacy as good as or better than topical antifungal agents. A small percentage (< 5%) of women experience chronic recurrent VVC infections, which often require long-term or prophylactic oral azole therapy for control. In such patients, the recommended regimen includes fluconazole 150 mg every other day for 3 doses, followed by weekly fluconazole 150-200 mg for 6 months
A.FLUCOBAZOLE
B.NYSTATIN
C.GRISEOFULVIN
D.COTRIMAZOLE
ANS:FLUCONAZOLE
Vulvovaginal candidiasis (VVC) can be managed with either topical antifungal agents or a single dose of oral fluconazole. A single dose of oral fluconazole (150 mg) in acute episodes of VVC has been shown to yield clinical and microbiological efficacy as good as or better than topical antifungal agents. A small percentage (< 5%) of women experience chronic recurrent VVC infections, which often require long-term or prophylactic oral azole therapy for control. In such patients, the recommended regimen includes fluconazole 150 mg every other day for 3 doses, followed by weekly fluconazole 150-200 mg for 6 months
No comments:
Post a Comment